Neuralink Aims to Restore Partial Vision for the Blind by 2026

IT Home, September 7 — Elon Musk stated that Neuralink Corp may attempt to restore partial vision to visually impaired patients as early as 2026.

Currently, Neuralink’s “Telepathy” implant has been successfully implanted for the first time outside the United States, and Elon Musk shared this latest development on the social media platform X.

Neuralink’s official X account released information about its first Canadian patient. In the comments, Elon Musk wrote that the company “aims to restore (partial) vision to completely blind individuals next year.” If this “Blindsight” device becomes a reality, it will significantly improve patients’ quality of life. Currently, Neuralink’s “Telepathy” implant is already transforming patients’ lives, and the future “Blindsight” device is highly likely to achieve similar success.

IT Home noted that this is not the first time Musk has disclosed progress on the “Blindsight” trial. Earlier this year, he revealed at the Qatar Economic Forum that the first human implantation surgery for the “Blindsight” device might take place in early 2026, possibly in the United Arab Emirates. It is reported that Neuralink has discussed collaboration with the Cleveland Clinic Abu Dhabi regarding the initial surgeries. In addition, the U.S. Food and Drug Administration (FDA) has designated the “Blindsight” device as a “Breakthrough Device,” further reflecting the progress made in the development of this implantable device.

Elon Musk previously introduced “Blindsight” as a brain-computer interface (BCI) developed by Neuralink, with the core function of helping patients restore their vision. During Neuralink’s “Show and Tell” event in 2022, he mentioned that the device would directly stimulate the visual cortex, completely bypassing damaged ocular tissues to generate visual perception. This means that even individuals with congenital blindness may potentially regain sight through this device.

Musk stated, “We plan to initially launch two applications in humans, one of which is restoring vision. Notably, we believe we can help restore vision even in individuals who have never had visual experience, such as those with congenital blindness. The visual cortex in the brain remains intact; even though they have never seen the world, we are confident in our ability to help them regain their sight.”